The rise in the prevalence of diabetes is attributed to changes in human behavior, environment, and lifestyle. The prolonged survival of diabetes patients has been made possible by better care, but this is accompanied by chronic long-term problems brought on by hyperglycemia. Diabetes-related conditions like ketoacidosis or hypoglycemia are fewer common causes of death for diabetics than cardiovascular disease (CVD). Cardiovascular disease is more common in diabetes patients by a factor of 2 to 6 compared to the general population. Additionally, diabetics with CVD have a worse prognosis for survival than those with CVD who don't have diabetes, and their quality of life also declines. As a result, diabetes has been compared to a non-diabetic patient who has a history of heart disease in terms of risk. Identifying patients with a high risk of developing CVD can help prevent or delay cardiovascular events. Chemists must closely monitor these issues to manage CVD prevention and related ones. Patients taking aspirin and clopidogrel for an extended period should be constantly monitored due to the possibility of resistance. Guidelines have been developed to monitor and manage aspirin and clopidogrel in CVD preventive therapy.
Over 7 million patients worldwide have end arterial interventional radiology procedures (EAIRP). These procedures are now a standard tool in vascular surgery. On the other hand, little is known about the infections connected to these medical procedures. It's possible to underestimate the prevalence and adverse effects of infectious complications (IC) after EAIRP. Our objective is to calculate the incidence and outcome trends across the country for EAIRP. The PMSI's database is instantly accessible and has been amassed over time. The Common Classification of Medical Acts codes represents the homogeneous population to evaluate endovascular interventional radiology therapy. Through various stages of the study, this protocol will call for proficiency in medicine, epidemiology, statistics, data processing, and procedures.
Patients who are nearing the end of their life frequently take numerous drugs. Physicians often are unaware of the significance of assessing a patient's medication's usefulness near the end of their life. The purpose of this study is to learn more about how patients, unpaid caregivers, nurses, and doctors view the role of nurses in managing medication near the end of life. By educating, encouraging, advocating for, and involving all pertinent stakeholders, we discovered that nurses could and should play a significant role in administering medications near the end of life. To improve the administration of drugs to patients nearing the end of their lives, doctors should value nurses' advice. The importance that nurses can play in encouraging patients' interest in drug management at the end of life should be acknowledged by healthcare providers. To fulfil this function, nurses should be strengthened through education and training.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.